# Falcon Registry (Exact Sciences multi-cancer test real-world evidence)

Source: https://onco.cc/trials/falcon-registry/  
OnCo record `falcon-registry` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A registry of up to 25,000 people who have the Exact Sciences multi-cancer blood test, following what happens after their results.

## Summary

Falcon Registry (NCT06589310) is an observational study sponsored by Exact Sciences Corporation. It is a multi-site registry of patients receiving the Exact Sciences multi-cancer early detection test.

The registry record, read on 29 October 2026, gives its status as recruiting, with an estimated 25,000 participants, a start on 1 August 2024 and primary completion expected in August 2030.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-10-29
- Also known as: Falcon; Falcon Real World Evidence Registry
- Registry id: NCT06589310
- Phase: observational
- Setting: People in the United States receiving the Exact Sciences multi-cancer early detection test in routine care
- Sponsor: Exact Sciences Corporation
- Enrolled: 25000

## Sources

- ClinicalTrials.gov NCT06589310: https://clinicaltrials.gov/study/NCT06589310

## Connected records

- fronts: [Early Detection & Screening](https://onco.cc/fronts/early-detection/)
- technologies: [Liquid biopsy (ctDNA)](https://onco.cc/technologies/liquid-biopsy/), [Multi-cancer early detection (MCED)](https://onco.cc/technologies/mced/)
- drugs: [Cancerguard](https://onco.cc/drugs/cancerguard/)
- companies: [Exact Sciences (Abbott)](https://onco.cc/companies/exact-sciences/)

---
JSON: https://onco.cc/api/v1/entities/falcon-registry.json